XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and contingencies (Tables)
6 Months Ended
Jun. 30, 2020
AbbVie Tau Collaboration Agreement  
Schedule of allocation of transaction price

Performance Obligation

Amount

(in thousands)

Research Services

$

34,482

First Development Option Material Right

34,518

Total

$

69,000

AbbVie Alpha Synuclein Collaboration Agreement  
Schedule of allocation of transaction price

Performance Obligation

Amount

(in thousands)

ASN Research Services

$

23,768

ASN First Development Option Material Right

41,232

Total

$

65,000

Neurocrine Collaboration Agreement  
Schedule of allocation of variable consideration

Performance Obligation

Amount

(in thousands)

Variable Consideration

VY-AADC Program

$

83,983

FA Program

113,033

Discovery Program 1

72,164

Discovery Program 2

71,262

Total

$

340,442

Schedule of allocation of fixed consideration

Performance Obligation

Amount

(in thousands)

Fixed Consideration

VY-AADC Program

$

80,373

FA Program

6,005

Discovery Program 1

3,002

Discovery Program 2

3,002

Total

$

92,382